Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Cannabidiol in Opioid Use Disorder and Chronic Pain [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial at Yale evaluating cannabidiol for chronic pain and opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Yale University | Conditions: Chronic Pain, Opioid Use Disorder | EARLY_Phase 1 | Status: RECRUITING